Agilysys inc (AGYS)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10
Less: Income from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19,992

22,709

25,279

4,581

4,916

7,852

5,498

14,921

14,710

0

0

0

-

-

-

-

Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,895

-3,273

-2,665

-2,770

-6,214

-26,458

-31,130

-33,269

-37,493

0

0

0

-

-

-

-

Operating activities
Net loss

-34,067

-10,664

-12,129

-13,003

-13,164

-9,787

-7,672

-7,128

-8,350

-13,425

-13,230

-12,382

-11,721

-7,972

-7,908

-5,877

-3,765

-7,653

-8,695

-9,453

-11,497

-8,080

-8,027

13,552

17,097

19,436

22,614

1,811

-1,298

-18,606

-25,632

-18,348

-22,783

-50,812

-42,304

-51,451

-55,475

0

0

0

Adjustments to reconcile net loss to net cash provided by operating activities:
Restructuring, severance and other charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

794

557

425

1,495

6,181

10,768

14,026

15,247

10,589

6,036

2,358

405

0

0

0

Net restructuring, severance and other charges

-

0

0

182

-

0

0

-254

-

781

-81

-153

224

157

1,062

1,030

333

-501

-1,400

-1,159

-134

-1,457

276

712

349

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from legal settlements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Impairments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

120

0

0

0

-

-

-

-

-

-

-

-

Payments and settlements for restructuring

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

-

-

-

-

Net legal settlements

-

-

-

76

-

-

-

-91

-

150

85

0

100

0

0

0

-

-

-

-

-

-

1,737

1,668

110

87

87

87

0

0

0

0

-

-

-

-

-

-

-

-

Depreciation

2,574

2,345

2,142

2,111

2,504

2,672

2,601

2,626

2,631

2,510

2,528

2,422

2,409

2,363

2,333

2,279

2,199

2,150

2,138

2,129

2,225

2,205

2,226

2,207

2,074

2,069

2,000

2,033

2,137

2,425

2,980

3,536

3,963

4,583

4,242

3,786

3,914

0

0

0

Amortization of intangibles

2,541

2,575

2,642

2,702

2,567

2,350

2,146

1,937

1,879

1,782

1,664

1,541

1,392

570

1,305

1,282

1,243

1,226

1,090

1,686

3,461

6,612

8,137

8,064

6,726

4,919

3,495

3,719

4,089

4,273

4,601

5,380

5,807

6,546

7,038

6,428

7,343

0

0

0

Contingent consideration adjustment

-

-

-

-

-

-

-

-

-

-

-

-

-

-104

-104

-104

93

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of developed technology

12,561

12,677

12,895

13,114

12,602

12,002

11,299

10,372

10,016

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income taxes

-356

-48

16

332

309

-4,255

-2,944

-3,007

-3,085

1,177

-119

-184

-142

-128

-209

-127

-23

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,449

0

0

0

Share-based compensation

5,205

4,576

4,529

4,449

4,376

3,868

4,044

3,878

4,688

5,421

3,904

3,300

2,427

1,869

2,846

3,347

3,405

3,630

3,473

3,179

3,140

2,423

2,304

2,119

2,119

2,156

1,953

1,851

1,638

1,053

975

1,068

2,397

3,087

3,364

3,614

2,812

0

0

0

Change in cash surrender value of company owned life insurance policies

-

0

0

15

-

0

0

15

-

7

14

19

18

564

574

569

564

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Gain on redemption of corporate-owned life insurance policies

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Accounts receivable

-

-

-

-

-

-

-

-

-

-

-

-

-6,372

-5,378

-701

-1,692

-3,237

-250

-6,359

-2,994

1,935

-452

6,170

5,899

7,846

2,397

3,856

1,802

741

9,442

5,363

707

3,396

-30,672

-20,766

-25,343

-10,256

0

0

0

Inventories

-

-

-

-

-

-

-

-

-

-

-

-

-476

-242

1,097

1,759

2,051

1,697

517

-373

171

-431

71

337

-380

-316

228

-493

-426

-17

-3,262

-5,335

645

866

481

-4,801

859

0

0

0

Prepaid expense and other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expense and other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,532

3,620

807

758

526

-401

-235

206

498

1,378

1,120

618

801

0

0

0

-

-

-

-

-

-

-

-

Accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

554

-2,783

498

-1,761

-7,896

1,184

-150

941

5,528

433

673

527

1,073

-2,507

1,054

551

1,595

216

-256

-9,343

-1,700

-23,906

-22,906

-30,911

-20,477

0

0

0

Contract liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-4,034

-753

8,347

6,947

9,364

11,197

901

556

1,146

324

2,414

4,098

2,784

-1,016

-868

-3,236

-5,046

12,347

7,345

9,245

7,775

0

0

0

-

-

-

-

Accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-4,250

7,166

5,387

4,336

5,330

-4,421

-4,195

-649

-3,868

-3,710

1,424

403

1,624

4,531

1,532

1,281

-3,170

-3,962

-13,596

-9,868

-2,600

-4,085

3,690

-419

-2,499

0

0

0

Income taxes payable

-

-

-

-

-

-

-

-

-

-

-

-

45

55

-76

-33

16

59

128

113

-823

-5,160

-3,055

-3,246

-2,702

906

-3,225

-3,413

-2,960

-9,818

-5,469

-4,939

-5,958

9,166

6,427

6,727

7,562

0

0

0

Other changes, net

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities

-

-

-

0

-

-

-

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,431

-591

-727

-1,150

-1,446

-239

-1,615

0

0

0

Net cash provided by (used in) operating activities from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,384

-1,997

-2,478

-3,814

-13,050

-21,077

-25,753

-18,828

-12,679

0

0

0

-

-

-

-

Net cash used in operating activities from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,311

159

4,867

6,452

2,345

19,683

14,580

-1,443

-9,019

0

0

0

-

-

-

-

Other non-cash adjustments, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Total adjustments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Net cash provided by operating activities

10,575

10,795

11,223

6,691

7,241

6,495

5,774

5,995

6,874

138

1,969

3,968

3,433

4,297

7,258

8,064

7,218

13,597

7,094

4,136

-2,186

1,125

-753

-1,650

73

-1,838

2,389

2,638

-10,705

-1,394

-11,173

-20,271

-21,698

-6,655

-2,549

8,866

14,783

0

0

0

Investing activities
Proceeds from sale of business units

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

35,846

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for acquisitions, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,812

-1,801

1,750

1,750

0

0

0

0

-

-

-

-

-

-

-

-

Investment in marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,240

10,240

10,240

10,240

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,347

8,506

11,495

13,516

9,184

5,172

2,183

162

161

0

0

0

Additional investments in corporate-owned life insurance policies and marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

Proceeds from redemption of/borrowings against corporate-owned life insurance policies

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Capital expenditures

3,420

4,717

3,925

3,145

3,318

2,461

4,367

4,759

6,140

6,120

4,992

5,465

4,158

5,610

5,892

5,506

5,900

4,411

3,180

4,631

4,650

4,671

5,348

3,877

4,023

4,210

4,220

3,377

2,532

672

1,504

2,007

2,231

1,788

1,348

2,654

3,427

0

0

0

Capitalized software development costs

-

-

-

57

2,189

3,835

5,630

8,060

8,918

9,986

11,541

12,008

11,888

37,710

30,803

23,490

15,048

14,865

5,600

14,194

15,813

7,893

7,629

6,390

12,200

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

Additional (investments in) corporate-owned life insurance policies

27

26

27

27

27

27

27

27

27

-2,155

-2,180

-2,180

-2,181

131

87

87

65

-3,895

-1,807

59

-1,905

2,099

-36

-1,898

87

-64

70

104

108

0

0

0

-

-

-

-

-

-

-

-

Net cash (used in) provided by investing activities from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17,724

19,531

22,374

-10,180

-2,199

39,806

2,918

64,238

60,443

0

0

0

-

-

-

-

Net cash used in investing activities from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-155

-258

-459

-821

-854

-858

-653

-284

-104

0

0

0

-

-

-

-

Net cash used in investing activities

-3,447

-4,743

-3,952

-3,229

-5,534

-6,323

-10,024

-12,846

-15,085

-13,951

-14,353

-15,293

-13,865

-16,345

-16,878

-17,897

-21,013

-16,257

-11,234

-15,280

-21,632

-27,513

-31,929

9,543

17,569

19,273

21,915

-11,001

-3,053

38,948

2,265

63,954

60,339

19,226

56,144

-6,737

-5,710

0

0

0

Exercise of employee stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

67

67

155

67

210

0

0

0

-

-

-

-

Repurchase of common shares to satisfy employee tax withholding

1,092

1,088

1,143

1,178

647

593

1,209

1,401

1,171

1,319

648

452

533

404

404

369

435

435

435

412

373

556

508

714

912

859

921

889

278

269

489

844

1,449

0

0

0

-

-

0

0

Principal payments under long-term obligations

24

48

73

92

120

122

122

123

124

123

122

124

117

199

178

156

142

141

141

141

144

156

162

167

177

85

108

419

289

435

669

564

1,001

933

615

599

370

0

0

0

Net cash used in financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-883

-671

-826

-1,014

-500

-1,683

-7,559

-14,808

-15,413

0

0

0

-

-

-

-

Net cash used in financing activities from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-80

-169

-277

-366

-377

-288

-102

-71

0

0

0

0

-

-

-

-

Net cash used in financing activities

-1,116

-1,136

-1,216

-1,270

-767

-715

-1,331

-1,524

-1,295

0

0

0

-

0

0

0

-

0

0

0

-

-663

-565

-675

-963

-840

-1,103

-1,380

-877

-1,971

-7,661

-14,879

-15,413

-14,465

-8,381

-1,073

-657

0

0

0

Effect of exchange rate changes on cash

-

-

-

-35

-

-

-

43

-

157

57

-3

-74

-91

-73

-167

-87

-221

-365

-247

-280

-197

-17

33

-44

-76

-96

18

-21

194

234

-143

5

50

86

652

403

0

0

0

Cash flows (used in) provided by continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18,181

16,787

18,974

-14,990

-15,770

17,240

-30,160

30,459

32,356

0

0

0

-

-

-

-

Cash flows used in discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,546

-268

4,131

5,265

1,114

18,537

13,825

-1,798

-9,123

0

0

0

-

-

-

-

Net decrease in cash and cash equivalents

-

-

-

2,157

-

-

-

-8,332

-

-15,098

-13,097

-11,904

-11,353

-12,939

-10,472

-10,722

-14,459

0

0

0

-

-

-

-

16,635

16,519

23,105

-9,725

-14,656

35,777

-16,335

28,661

23,233

-381

58,471

1,708

8,819

0

0

0

Accrued capital expenditures

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued capitalized software development costs

-

-

-

0

-

-

-

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-